ILMN Illumina, Inc. - Common Stock
$200,06
Prix · Aoû 19, 2026
Données fondamentales au Jul 31, 2026
Fourchette 52 semaines
$88–$207
94% of range
Note des analystes
BUY
28 analysts
Objectif de cours
$199
P/E (TTM)
48.2
ROE
34.1%
Marge nette
19.6%
À propos de Illumina, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Illumina, Inc. est une société américaine constituée en avril 1998, qui développe, fabrique et commercialise des systèmes intégrés pour l'analyse de la variation génétique et la fonction biologique.
Lire la suite
Illumina, Inc. est une société américaine constituée en avril 1998, qui développe, fabrique et commercialise des systèmes intégrés pour l'analyse de la variation génétique et la fonction biologique.
Grâce à ses technologies, la société fournit une gamme de produits et services qui servent les marchés du séquençage, génotypage et expression génétique. En 2013, cette technologie avait réduit le coût de séquençage de l'ADN à 4 000 dollars, comparé à 1 million de dollars en 2007.
Ses clients comprennent des centres de recherche génomique, des sociétés pharmaceutiques, des établissements universitaires, des organismes de recherche clinique et des sociétés de biotechnologie. Ses outils offrent aux chercheurs la possibilité d'effectuer des tests génétiques nécessaires pour extraire l'information médicale des progrès de la génomique et de la protéomique. Son siège social est situé à San Diego aux États-Unis.
Histoire
Illumina a été fondée en avril 1998 par David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, et Mark Chee. Tout en travaillant avec CW Group, une société de capital risque, Bock et Stuelpnagel découvrent ce qui allait devenir la technologie de Bead Array d'Illumina à l'Université Tufts et négocient une licence exclusive pour cette technologie. Illumina a complété son offre publique initiale en juillet 2000.
Illumina a commencé à offrir des services de génotypage de polymorphisme nucléotidique (SNP) en 2001 et a lancé son premier système, le Illumina BeadLab, en 2002, en utilisant la technologie de génotypage GoldenGate. Illumina offre actuellement des produits et services basés sur des microréseaux pour une gamme croissante de séquençage d'analyse génétique, y compris le génotypage de SNP, Expression génétique et la Protéomique. Les technologies de Illumina sont utilisés par un large éventail d'universitaires, de gouvernementaux, d'entreprises pharmaceutiques et biotechnologiques, et d'autres institutions de premier plan dans le monde entier.
Le 26 janvier 2007, la Société a complété l'acquisition de Solexa basée à Hayward, aux États-Unis. Solexa basée à Cambridge au Royaume-Uni a été fondée en juin 1998 par Shankar Balasubramanian et David Klenerman pour développer et commercialiser la technologie de séquençage du génome inventé par les fondateurs de l'Université de Cambridge. Solexa Inc.a en 2005 acquis Lynx Therapeutics. Elle utilise également la technique de séquençage de colonies d'ADN, inventé en 1997 par Pascal Mayer et Laurent Farinelli, depuis 2004, date du rachat de la société Manteia Predictive Medicine. Cette technologie est utilisée pour effectuer une série d'analyses, y compris le reséquençage du génome entier, l'analyse de l'expression des gènes et de petit acide ribonucléique (ARN).
En juin 2009, Illumina a annoncé le lancement de son propre service de séquençage génomique personnel à une profondeur de 30X pour 48 000 dollars par génome et un an plus tard a baissé le prix à 19 500 dollars puis à 4 000 dollars.
En janvier 2011, Illumina a acquis Epicentre Biotechnologies, basée à Madison dans le Wisconsin.
En janvier 2012, Roche a fait une offre non sollicitée pour acheter Illumina pour environ 5,7 milliards de dollars. Roche a essayé d'autres tactiques, notamment en augmentant à environ 6,8 milliards de dollars). Illumina a rejeté l'offre, et Roche a abandonné l'offre en avril.
En 2014, la société a annoncé un produit valant plusieurs millions de dollars, HiSeq X Dix, qui doit permettre le séquençage du génome entier pour 1 000 dollars par génome. La société a affirmé que quarante de ses machines seraient en mesure de séquencer plus de génomes en un an que ce qui avait été produit par tous les autres séquenceurs jusqu'à cette date. En janvier 2014, Illumina détenait déjà 70 % du marché des machines de séquençage. Les machines d'Illumina représentent plus de 90 % de toutes les données d'ADN acquises.
En mars 2016, Illumina a annoncé que Jay Flatley, le CEO depuis 1999, laisserait sa place à Francis DeSouza à partir de juillet 2016.
En novembre 2018, Illumina annonce l'acquisition de Pacific Biosciences pour 1,2 milliard de dollars. En janvier 2020, Illumina annonce l'abandon de l'opération sur Pacific Biosciences.
En septembre 2020, Illumina annonce l'acquisition pour 8 milliards de dollars de Grail, start-up spécialisée dans la détection du cancer créée en 2016 par Illumina et qui est restée son principal actionnaire avec une participation de 14,5 %.
En août 2022, La Commission européenne (CE) a annoncé interdire l'acquisition de la société américaine de biotechnologie du cancer GRAIL par Illumina, leader mondial du séquençage génétique. Elle a déclaré que l'acquisition de GRAIL par Illumina pour un montant 7,1 milliards de dollars entraverait la concurrence dans le domaine des tests sanguins pour la détection précoce du cancer. Cette acquisition de GRAIL a été contestée par l'investisseur activiste Carl Icahn dont le fonds Icahn Capital est présent au capital d'Illumina.
En octobre 2023, Carl Icahn annonce avoir assigné en justice les membres du conseil d'administration d'Illumina en lien avec l'acquisition ratée de GRAIL.
Principaux actionnaires
Références
Portail des entreprises Portail de San Diego
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
ILMN Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$200.06
Capitalisation Boursière
$40.21B
P/E (TTM)
48.2
BPA (TTM)
$5.45
Revenus (TTM)
$4.34B
Rendement div.
—
ROE
34.1%
Dette/Capitaux propres
0.2
Fourchette 52 semaines
$88 – $207
ILMN Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$4.34B
2017-01-01
→
2025-12-28
BPA
$5.45
2017-01-01
→
2025-12-28
Flux de trésorerie libre
$931M
2017-01-01
→
2025-12-28
Marges
19.6%
2017-01-01
→
2025-12-28
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ILMN
Médiane des pairs
P/E (TTM)
48.2
39.9
P/S (TTM)
9.3
5.6
P/B
14.8
4.1
Price / FCF (Cours / FCF)
43.2
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ILMN
Médiane des pairs
Gross Margin (Marge Brute)
66.1%
46.4%
Operating Margin (Marge d'exploitation)
18.6%
—
Net Profit Margin (Marge nette)
19.6%
11.7%
ROA
13.1%
4.7%
ROE
34.1%
8.5%
ROIC
19.6%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ILMN
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.2
15.3
Current Ratio (Ratio de liquidité)
2.1
1.7
Quick Ratio (Ratio de liquidité réduite)
0.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ILMN
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-0.66%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-1.8%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
6.0%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ILMN
Médiane des pairs
ILMN Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
28 analystes
- Achat fort 7 25,0%
- Achat 10 35,7%
- Conserver 8 28,6%
- Vente 2 7,1%
- Vente forte 1 3,6%
Objectif de cours à 12 mois
19 analystes · 2026-08-17
Médiane
$211.00
Moyenne
$198.89
Maintenant
$200.06
Bas
$113.00
Haut
$230.00
Objectif médian
$211.00
+5,5%
Objectif moyen
$198.89
-0,6%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.09%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $1.31 | $1.25 | 0.06% |
| 31 mars 2026 | $1.15 | $1.08 | 0.07% |
| 31 décembre 2025 | $1.15 | $1.08 | 0.07% |
| 30 septembre 2025 | $1.34 | $1.19 | 0.15% |
| 30 juin 2025 | $1.19 | $1.03 | 0.16% |
| 31 mars 2025 | $0.97 | $0.96 | 0.01% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Cost of Revenue | $1.47B | $1.51B | $1.76B | $1.61B | $1.37B | $1.04B | $1.08B | $1.03B | $926M | $732M | $671M | $564M | |
| Gross Profit | $2.87B | $2.86B | $2.74B | $2.97B | $3.15B | $2.20B | $2.47B | $2.30B | $1.83B | $1.67B | $1.55B | $1.30B | |
| R&D Expense | $967M | $1.17B | $1.35B | $1.32B | $1.19B | $682M | $647M | $623M | $546M | $504M | $401M | $388M | |
| SG&A Expense | $1.09B | $1.09B | $1.61B | $1.30B | $2.09B | $941M | $835M | $794M | $674M | $584M | $516M | $466M | |
| Operating Expenses | $2.06B | $3.69B | $3.81B | $7.15B | $3.28B | $1.62B | $1.48B | $1.42B | $1.22B | $1.08B | $936M | $783M | |
| Operating Income | $807M | $-833M | $-1.07B | $-4.18B | $-123M | $580M | $985M | $883M | $606M | $587M | $613M | $515M | |
| Interest Expense | · | · | $77M | $26M | $61M | $49M | $52M | $57M | $37M | $33M | $43M | $42M | |
| Interest Income | $40M | $46M | $58M | $11M | $0 | $41M | $75M | $44M | $19M | $10M | $5M | $4M | |
| Other Non-op | $340M | $-292M | $-29M | $-142M | $1.07B | $284M | $110M | $24M | $455M | $-3M | $-8M | $-33M | |
| Pretax Income | $1.09B | $-1.18B | $-1.12B | $-4.34B | $884M | $856M | $1.12B | $894M | $1.04B | $561M | $583M | $449M | |
| Income Tax | $236M | $44M | $44M | $68M | $122M | $200M | $128M | $112M | $365M | $133M | $125M | $95M | |
| Net Income | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| EPS (Basic) | $5.47 | $-7.69 | $-7.34 | $-28.00 | $5.07 | $4.48 | $6.81 | $5.63 | $4.96 | $3.09 | $3.19 | $2.61 | |
| EPS (Diluted) | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 | $4.45 | $6.74 | $5.56 | $4.92 | $3.07 | $3.10 | $2.37 | |
| Shares (Basic) | 155,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 150,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 147,000,000 | 145,000,000 | 135,553,000 | |
| Shares (Diluted) | 156,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 151,000,000 | 148,000,000 | 149,000,000 | 149,000,000 | 148,000,000 | 148,000,000 | 149,000,000 | 148,977,000 | |
| EBITDA | $1.08B | $-479M | $-637M | $-3.79B | $128M | $767M | $1.17B | $1.06B | $762M | $729M | $613M | · |
Bilan 29
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | $1.14B | $1.23B | $735M | $769M | $636M | |
| Short-term Investments | $215M | $93M | $6M | $26M | $107M | $1.66B | $1.37B | $2.37B | $920M | $824M | $617M | $702M | |
| Receivables | $854M | $735M | $734M | $671M | $648M | $487M | $573M | $514M | $411M | $381M | $386M | $289M | |
| Inventory | $564M | $547M | $587M | $568M | $431M | $372M | $359M | $386M | $333M | $300M | $271M | $191M | |
| Prepaid Expense | $238M | $244M | $234M | $285M | $295M | $152M | $105M | $78M | $91M | $78M | $54M | $30M | |
| Current Assets | $3.29B | $2.75B | $2.61B | $3.56B | $2.71B | $4.48B | $4.45B | $4.49B | $2.98B | $2.32B | $2.10B | $1.89B | |
| PP&E (Net) | $759M | $815M | $1.01B | $1.09B | $1.02B | $922M | $889M | $1.07B | $931M | $713M | $343M | $265M | |
| PP&E (Gross) | $2.12B | $2.07B | $2.15B | $2.05B | $1.82B | $1.60B | $1.46B | $1.60B | $1.35B | $1.04B | $609M | $480M | |
| Accum. Depreciation | $1.36B | $1.25B | $1.14B | $962M | $796M | $678M | $568M | $521M | $416M | $327M | $267M | $215M | |
| Goodwill | $1.11B | $1.11B | $2.54B | $3.24B | $7.11B | $897M | $897M | $831M | $771M | $776M | $753M | $725M | |
| Intangibles | $210M | $295M | $2.99B | $3.29B | $3.25B | $142M | $145M | $185M | $175M | $243M | $274M | $314M | |
| Other Non-current Assets | $449M | $348M | $357M | $423M | $445M | $609M | $388M | $308M | $312M | $108M | $87M | $96M | |
| Total Assets | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Accounts Payable | $240M | $221M | $245M | $293M | $332M | $192M | $149M | $184M | $160M | $138M | $139M | $83M | |
| Accrued Liabilities | $846M | $827M | $1.32B | $1.23B | $761M | $541M | $516M | $513M | $432M | $342M | $387M | $335M | |
| Short-term Debt | $499M | $499M | $0 | $500M | $0 | · | · | · | · | · | · | · | |
| Current Liabilities | $1.58B | $1.55B | $1.57B | $2.77B | $1.09B | $1.24B | $665M | $1.80B | $746M | $705M | $610M | $722M | |
| Capital Leases | $486M | $554M | $687M | $744M | $774M | $671M | $695M | · | · | · | · | · | |
| Other Non-current Liabilities | $360M | $339M | $620M | $649M | $915M | $303M | $202M | $359M | $360M | $206M | $181M | $168M | |
| Long-term Debt | · | · | · | · | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.06B | $1.09B | $1.29B | |
| Total Debt | $499M | $499M | $0 | $500M | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.05B | $1.09B | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $7.82B | $7.53B | $9.55B | $9.21B | $8.94B | $3.81B | $3.56B | $3.29B | $2.83B | $2.73B | $2.50B | $2.17B | |
| Retained Earnings | $-392M | $-1.24B | $-19M | $1.14B | $5.49B | $4.72B | $4.07B | $3.08B | $2.26B | $1.49B | $1.02B | $561M | |
| Treasury Stock | $4.70B | $3.93B | $3.79B | $3.75B | $3.70B | $3.85B | $3.02B | $2.62B | $2.34B | $2.02B | $1.67B | $1.27B | |
| AOCI | $-10M | $22M | $-1M | $3M | $17M | $2M | $5M | $-1M | $-1M | $-1M | $36.0K | $-1M | |
| Stockholders' Equity | $2.72B | $2.37B | $5.75B | $6.60B | $10.74B | $4.69B | $4.61B | $3.85B | $2.75B | $2.20B | $1.85B | $1.46B | |
| Liabilities + Equity | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Shares Outstanding | 201,000,000 | 200,000,000 | 199,000,000 | 198,000,000 | 197,000,000 | 195,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 146,584,000 | 143,629,000 |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $270M | $354M | $432M | $394M | $251M | $187M | $188M | $179M | $156M | $141M | $127M | $113M | |
| Stock-based Comp | $275M | $370M | $380M | $366M | $754M | $194M | $194M | $193M | $164M | $129M | $133M | $153M | |
| Deferred Tax | $119M | $-117M | $-34M | $-23M | $-76M | $117M | $5M | $-18M | $34M | $7M | $-45M | $-20M | |
| Amort. of Intangibles | $67M | $130M | $197M | $179M | $75M | $31M | $37M | $39M | $46M | $51M | $54M | $51M | |
| Restructuring | $47M | $16M | $52M | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-435M | $1.45B | $861M | $4.06B | $-1.15B | $-74M | $-338M | $-38M | $-205M | $-53M | · | · | |
| Operating Cash Flow | $1.08B | $837M | $478M | $392M | $545M | $1.08B | $1.05B | $1.14B | $875M | $779M | $786M | $501M | |
| CapEx | $148M | $128M | $195M | $286M | $208M | $189M | $209M | $296M | $310M | $260M | $143M | $106M | |
| Investing Cash Flow | $-55M | $-178M | $-231M | $-591M | $-1.07B | $-554M | $745M | $-1.81B | $-214M | $-515M | $-107M | $-407M | |
| Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | $1.13B | |
| Net Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | · | |
| Stock Issued | $44M | $56M | $67M | $63M | $60M | $61M | $59M | $46M | $71M | $47M | $72M | $96M | |
| Stock Repurchased | $742M | $116M | $0 | $0 | $0 | $736M | $324M | $201M | $251M | $249M | $274M | $237M | |
| Net Stock Activity | $-698M | $-60M | $67M | $63M | $60M | $-675M | $-265M | $-155M | $-180M | $-202M | $-202M | · | |
| Financing Cash Flow | $-744M | $-570M | $-1.21B | $1.00B | $-51M | $-766M | $-897M | $594M | $-176M | $-296M | $-545M | $-167M | |
| Net Change in Cash | $291M | $79M | $-963M | $779M | $-578M | $-232M | $898M | $-81M | $490M | $-34M | $133M | $-75M | |
| Taxes Paid | $73M | $105M | $65M | $122M | $233M | $119M | $164M | $99M | $149M | $60M | $17M | $18M | |
| Free Cash Flow | $931M | $709M | $283M | $106M | $337M | $891M | $842M | $846M | $565M | $427M | $517M | · | |
| Levered FCF | · | · | $203M | $80M | $284M | $853M | $796M | $796M | $541M | $402M | $484M | · |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% | 68.0% | 69.6% | 69.0% | 66.3% | 69.5% | 69.8% | · | |
| Operating Margin | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% | 17.9% | 27.8% | 26.5% | 22.0% | 24.5% | 27.6% | · | |
| Net Margin | 19.6% | -28.0% | -25.8% | -96.1% | 16.8% | 20.2% | 28.3% | 24.8% | 26.4% | 19.3% | 20.8% | · | |
| Pretax Margin | 25.0% | -27.0% | -24.8% | -94.6% | 19.5% | 26.4% | 31.6% | 26.8% | 37.9% | 23.4% | 26.3% | · | |
| EBITDA Margin | 24.8% | -11.0% | -14.1% | -82.6% | 2.8% | 23.7% | 33.1% | 31.9% | 27.7% | 30.4% | 27.6% | · | |
| ROA | 13.1% | -14.9% | -10.4% | -32.1% | 6.7% | 8.8% | 14.0% | 13.5% | 15.2% | 11.6% | 13.1% | · | |
| ROE | 34.1% | -54.4% | -19.9% | -66.1% | 7.1% | 14.0% | 22.1% | 25.4% | 29.4% | 22.9% | 27.9% | · | |
| ROIC | 19.6% | -30.1% | -19.3% | -59.8% | -0.99% | 7.6% | 15.2% | 13.4% | 10.0% | 13.8% | 16.4% | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 | 3.6 | 6.7 | 2.5 | 4.0 | 3.3 | 3.4 | · | |
| Quick Ratio | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 | 1.7 | 2.9 | 2.2 | 3.4 | 2.8 | 2.9 | · | |
| Debt / Equity | 0.2 | 0.2 | 0.0 | 0.1 | · | 0.3 | 0.2 | 0.5 | 0.4 | 0.5 | 0.6 | · | |
| LT Debt / Equity | · | · | · | · | · | 0.1 | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | · | |
| Interest Coverage | · | · | -13.9 | -160.7 | -2.0 | 11.8 | 18.9 | 15.5 | 16.4 | 17.7 | 14.5 | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.5 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.7 | 2.7 | 3.0 | 3.2 | 3.4 | 2.8 | 2.9 | 2.9 | 2.9 | 2.6 | 2.9 | · | |
| Receivables Turnover | 5.5 | 6.0 | 6.4 | 7.0 | 8.0 | 6.1 | 6.5 | 7.2 | 6.9 | 6.3 | 6.6 | · |
Taux de croissance 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.66% | -2.9% | -1.8% | 1.3% | 39.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.8% | -1.1% | 11.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 13.3% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 16.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Net Income TTM | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| Market Cap | $20.65B | $21.51B | $21.54B | $31.08B | $58.10B | $52.55B | $47.52B | $42.65B | $31.24B | $18.21B | $27.37B | · | |
| Enterprise Value | · | · | · | · | · | · | · | $41.13B | $30.29B | $17.70B | $27.07B | · | |
| P/E | 24.8 | -17.6 | -18.5 | -7.0 | 73.4 | 80.9 | 48.0 | 52.2 | 43.2 | 40.6 | 60.2 | 77.2 | |
| P/S | 4.8 | 4.9 | 4.8 | 6.8 | 12.8 | 16.2 | 13.4 | 12.8 | 11.4 | 7.6 | 12.3 | · | |
| P/B | 7.6 | 9.1 | 3.7 | 4.7 | 5.4 | 11.2 | 10.3 | 11.3 | 11.4 | 8.3 | 14.8 | · | |
| P / Tangible Book | 14.7 | 22.3 | 104.0 | 414.4 | 154.1 | 14.4 | · | · | · | · | · | · | |
| P / Cash Flow | 19.1 | 25.7 | 45.1 | 79.3 | 106.6 | 48.7 | 45.2 | 37.3 | 35.7 | 26.5 | 41.5 | · | |
| P / FCF | 22.2 | 30.3 | 76.1 | 293.2 | 172.4 | 59.0 | 56.4 | 50.4 | 55.3 | 42.6 | 53.0 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | 38.7 | 39.8 | 24.3 | 44.2 | · | |
| EV / FCF | · | · | · | · | · | · | · | 48.6 | 53.6 | 41.4 | 52.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | 12.3 | 11.0 | 7.4 | 12.2 | · | |
| Earnings Yield | 4.0% | -5.7% | -5.4% | -14.2% | 1.4% | 1.2% | 2.1% | 1.9% | 2.3% | 2.5% | 1.7% | 1.3% |
Compte de résultat 18
| Métrique | Tendance | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.09B | $1.16B | $1.08B | $1.06B | $1.04B | $1.10B | $1.08B | $1.11B | $1.08B | $1.02B | $1.18B | $1.09B | $1.11B | |
| Cost of Revenue | $389M | $370M | $400M | $351M | $364M | $358M | $376M | $335M | $391M | $409M | $476M | $444M | $432M | $480M | |
| Gross Profit | $770M | $721M | $759M | $733M | $695M | $683M | $728M | $745M | $721M | $667M | $542M | $732M | $655M | $626M | |
| R&D Expense | $252M | $240M | $239M | $229M | $247M | $252M | $252M | $253M | $325M | $339M | $332M | $358M | $341M | $474M | |
| SG&A Expense | $273M | $272M | $308M | $277M | $234M | $267M | $267M | $239M | $147M | $439M | $464M | $462M | $378M | $205M | |
| Operating Expenses | $525M | $512M | $557M | $506M | $481M | $519M | $554M | $4M | $2.36B | $778M | $1.64B | $820M | $719M | $4.60B | |
| Operating Income | $245M | $209M | $202M | $227M | $214M | $164M | $174M | $741M | $-1.64B | $-111M | $-1.10B | $-88M | $-64M | $-3.98B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $18M | · | $19M | $20M | · | |
| Interest Income | $8M | $11M | $10M | $9M | $10M | $11M | $10M | $11M | $13M | $12M | $24M | $17M | $17M | $9M | |
| Other Non-op | $31M | $-39M | $192M | $9M | $107M | $32M | $28M | $4M | $-332M | $8M | $19M | $1M | $-11M | $-45M | |
| Pretax Income | $260M | $157M | $378M | $220M | $306M | $182M | $186M | $720M | $-1.98B | $-109M | $-1.09B | $-89M | $-78M | $-4.01B | |
| Income Tax | $53M | $23M | $44M | $70M | $71M | $51M | $0 | $15M | $12M | $17M | $-74M | $145M | $-81M | $94M | |
| Net Income | $207M | $134M | $334M | $150M | $235M | $131M | $186M | $705M | $-1.99B | $-126M | $-791M | $-234M | $3M | $-4.10B | |
| EPS (Basic) | $1.37 | $0.88 | $2.17 | $0.98 | $1.49 | $0.83 | $1.15 | $4.43 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.16 | |
| EPS (Diluted) | $1.35 | $0.87 | $2.16 | $0.98 | $1.49 | $0.82 | $1.16 | $4.42 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.15 | |
| Shares (Basic) | 151,000,000 | 153,000,000 | -314,000,000 | 153,000,000 | 157,000,000 | 159,000,000 | -318,000,000 | 159,000,000 | 159,000,000 | 159,000,000 | -315,000,000 | 158,000,000 | 158,000,000 | -303,000,000 | |
| Shares (Diluted) | 153,000,000 | 154,000,000 | -314,000,000 | 154,000,000 | 157,000,000 | 159,000,000 | -319,000,000 | 160,000,000 | 159,000,000 | 159,000,000 | -317,000,000 | 158,000,000 | 158,000,000 | -306,000,000 | |
| EBITDA | $245M | $209M | · | $294M | $282M | $233M | · | $741M | $-1.64B | $-111M | · | $-88M | $-64M | · |
Bilan 27
| Métrique | Tendance | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Short-term Investments | $128M | $66M | $215M | $228M | $221M | $124M | $93M | $70M | $74M | · | · | $6M | $24M | · | |
| Receivables | $764M | $738M | $854M | $729M | $701M | $699M | $735M | $699M | $641M | $635M | · | $741M | $665M | · | |
| Inventory | $629M | $611M | $564M | $590M | $575M | $537M | $547M | $574M | $561M | $584M | · | $617M | $586M | · | |
| Prepaid Expense | $273M | $234M | $238M | $199M | $210M | $200M | $244M | $161M | $263M | $256M | · | $306M | $403M | · | |
| Current Assets | $2.83B | $2.74B | $3.29B | $2.80B | $2.64B | $2.67B | $2.75B | $2.37B | $2.46B | $2.58B | · | $3.22B | $3.17B | · | |
| PP&E (Net) | $745M | $755M | $759M | $748M | $764M | $782M | $815M | $832M | $859M | $964M | · | $1.07B | $1.08B | · | |
| PP&E (Gross) | · | · | $2.12B | · | · | · | $2.07B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.36B | · | · | · | $1.25B | · | · | · | · | · | · | · | |
| Goodwill | $1.28B | $1.28B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.08B | $2.54B | $2.54B | $3.24B | $3.24B | $3.24B | |
| Intangibles | $410M | $430M | $210M | $225M | $238M | $278M | $295M | $305M | $278M | $2.94B | · | $3.19B | $3.24B | · | |
| Other Non-current Assets | $576M | $523M | $449M | $423M | $400M | $373M | $348M | $321M | $314M | $458M | · | $417M | $423M | · | |
| Total Assets | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Accounts Payable | $230M | $218M | $240M | $218M | $200M | $207M | $221M | $191M | $199M | $201M | · | $244M | $242M | · | |
| Accrued Liabilities | $848M | $849M | $846M | $746M | $762M | $734M | $827M | $784M | $1.26B | $1.27B | · | $1.31B | $1.24B | · | |
| Short-term Debt | $500M | $499M | $499M | $998M | $499M | $499M | $499M | · | $744M | · | · | $0 | $0 | · | |
| Current Liabilities | $1.58B | $1.57B | $1.58B | $1.96B | $1.46B | $1.44B | $1.55B | $975M | $2.21B | $1.47B | · | $2.30B | $2.23B | · | |
| Capital Leases | $454M | $475M | $486M | $506M | $528M | $539M | $554M | $613M | $616M | $700M | · | $726M | $747M | · | |
| Other Non-current Liabilities | $289M | $352M | $360M | $334M | $348M | $344M | $339M | $313M | $331M | $642M | · | $702M | $654M | · | |
| Total Debt | $500M | $499M | · | $998M | $499M | $499M | · | · | $744M | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | · | |
| Paid-in Capital | $7.93B | $7.86B | $7.82B | $7.76B | $7.68B | $7.61B | $7.53B | $7.45B | $7.35B | $9.66B | · | $9.40B | $9.31B | · | |
| Retained Earnings | $-51M | $-258M | $-392M | $-726M | $-876M | $-1.11B | $-1.24B | $-1.43B | $-2.13B | $-145M | · | $911M | $1.15B | · | |
| Treasury Stock | $5.05B | $4.93B | $4.70B | $4.64B | $4.52B | $4.14B | $3.93B | $3.89B | $3.79B | $3.79B | · | $3.77B | $3.76B | · | |
| AOCI | $8M | $1M | $-10M | $-12M | $-21M | $8M | $22M | $-5M | $14M | $12M | · | $12M | $-1M | · | |
| Stockholders' Equity | $2.84B | $2.68B | $2.72B | $2.38B | $2.26B | $2.37B | $2.37B | $2.12B | $1.44B | $5.73B | $5.75B | $6.55B | $6.69B | $6.60B | |
| Liabilities + Equity | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Shares Outstanding | 201,000,000 | 201,000,000 | 153,000,000 | 201,000,000 | 201,000,000 | 201,000,000 | 159,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 198,000,000 | 198,000,000 | 198,000,000 |
Flux de trésorerie 17
| Métrique | Tendance | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $66M | $67M | $68M | $69M | $71M | $70M | $105M | $108M | · | · | · | $232M | |
| Stock-based Comp | $73M | $60M | $63M | $70M | $69M | $73M | $79M | $83M | $112M | $96M | $94M | · | $93M | $100M | |
| Amort. of Intangibles | $19M | $18M | $16M | $17M | $17M | $17M | $17M | $17M | $47M | $49M | $57M | $49M | $50M | $112M | |
| Restructuring | · | · | $6M | $2M | $8M | $31M | $2M | $6M | $4M | $4M | · | $26M | · | · | |
| Other Non-cash | · | · | · | · | · | $-33M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $201M | $289M | $321M | $284M | $234M | $240M | $364M | $316M | $80M | $77M | $224M | · | $10M | $147M | |
| CapEx | $40M | $38M | $55M | $31M | $30M | $32M | $29M | $32M | $31M | $36M | $51M | · | $52M | $88M | |
| Investing Cash Flow | $-122M | $-366M | $108M | $-51M | $-49M | $-63M | $-48M | $-41M | $-41M | $-48M | $-85M | · | $-56M | $-102M | |
| Debt Issued | · | · | $495M | · | · | · | $0 | · | · | · | · | · | · | $3M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $-500M | · | |
| Stock Issued | $0 | $24M | $0 | $16M | $1M | $27M | $0 | $20M | $0 | $36M | $0 | · | $37M | $0 | |
| Stock Repurchased | $128M | $242M | $42M | $130M | $370M | $200M | $17M | $99M | $0 | $0 | $0 | · | · | $0 | |
| Net Stock Activity | · | $-218M | · | · | · | $-173M | · | · | · | $36M | · | · | $37M | · | |
| Financing Cash Flow | $-129M | $-251M | $-63M | $-115M | $-371M | $-195M | $-47M | $-332M | $-226M | $35M | $-27M | · | $-473M | $956M | |
| Net Change in Cash | $-49M | $-329M | $368M | $116M | $-179M | $-14M | $258M | $-51M | $-188M | $60M | $121M | · | $-517M | $1.01B | |
| Free Cash Flow | · | $251M | · | · | · | $208M | · | · | · | $41M | · | · | $-42M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $20M | · | · | $-41M | · |
Rentabilité 8
| Métrique | Tendance | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.4% | 66.1% | · | 67.6% | 65.6% | 65.6% | · | 69.0% | 64.8% | 62.0% | · | 62.2% | 60.3% | · | |
| Operating Margin | 21.1% | 19.2% | · | 20.9% | 20.2% | 15.8% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| Net Margin | 17.9% | 12.3% | · | 13.8% | 22.2% | 12.6% | · | 65.3% | -178.8% | -11.7% | · | -19.9% | 0.28% | · | |
| Pretax Margin | 22.4% | 14.4% | · | 20.3% | 28.9% | 17.5% | · | 66.7% | -177.7% | -10.1% | · | -7.6% | -7.2% | · | |
| EBITDA Margin | 21.1% | 19.2% | · | 27.1% | 26.6% | 22.4% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| ROA | 3.2% | 2.1% | · | 2.5% | 3.9% | 1.6% | · | 8.7% | -22.3% | -1.1% | · | · | · | · | |
| ROE | 8.1% | 5.3% | · | 6.7% | 12.7% | 3.2% | · | 17.6% | -49.8% | -2.0% | · | · | · | · | |
| ROIC | 5.8% | 5.6% | · | 4.6% | 6.0% | 4.1% | · | 34.1% | -75.5% | -2.2% | · | · | · | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.7 | · | 1.4 | 1.8 | 1.9 | · | 2.4 | 1.1 | 1.8 | · | · | · | · | |
| Quick Ratio | 0.6 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.8 | 0.3 | 0.4 | · | · | · | · | |
| Debt / Equity | 0.2 | 0.2 | · | 0.4 | 0.2 | 0.2 | · | · | 0.5 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.2 | · | -4.6 | -3.2 | · |
Efficacité 3
| Métrique | Tendance | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.7 | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.39B | $4.28B | · | $4.26B | $4.29B | $4.31B | · | $4.39B | $4.48B | $4.46B | · | $4.49B | $4.48B | · | |
| Net Income TTM | $825M | $853M | · | $702M | $1.26B | $-966M | · | $-1.58B | $-3.04B | $-1.29B | · | $-4.19B | · | · | |
| Market Cap | $35.49B | $23.65B | · | $18.43B | $19.05B | $16.08B | · | $25.89B | $20.77B | $26.58B | · | · | · | · | |
| P/E | 37.6 | 28.3 | · | 11.9 | -16.5 | -10.0 | · | -9.6 | -5.3 | -19.0 | · | -3.6 | -4.4 | · | |
| P/S | 8.1 | 5.5 | · | 4.3 | 4.4 | 3.7 | · | 5.9 | 4.6 | 6.0 | · | · | · | · | |
| P/B | 12.5 | 8.8 | · | 7.7 | 8.4 | 6.8 | · | 12.2 | 14.5 | 4.6 | · | · | · | · | |
| P / Tangible Book | 31.0 | 24.6 | · | 17.7 | 21.0 | 16.5 | · | 36.6 | 262.9 | 106.8 | · | · | · | · | |
| P / Cash Flow | · | 81.8 | · | · | · | 67.0 | · | · | · | 345.2 | · | · | · | · | |
| P / FCF | · | 94.2 | · | · | · | 77.3 | · | · | · | 648.4 | · | · | · | · | |
| Earnings Yield | 2.7% | 3.5% | · | 8.4% | -6.1% | -10.0% | · | -10.5% | -18.7% | -5.3% | · | -27.4% | -22.9% | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Revenu | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B |
| Marge Brute % | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% |
| Marge d'exploitation % | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% |
| Résultat net | $850M | $-1.22B | $-1.16B | $-4.40B | $762M |
| BPA dilué | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 |
Bilan
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.2 | 0.2 | 0.0 | 0.1 | — |
| Ratio de liquidité | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 |
| Ratio de liquidité réduite | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 |
Flux de trésorerie
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $931M | $709M | $283M | $106M | $337M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 1 006 déclarants · $18.3B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 165 (+52 vs T. préc.) | 60 (-34 vs T. préc.) | 296 (+14 vs T. préc.) | 321 (0 vs T. préc.) | +12.4M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Capital World Investors | $2 712 230 480 | 15 425 298 | 14,79% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 165 253 015 | 6 627 157 | 6,35% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 158 286 103 | 6 587 534 | 6,31% | Actions |
| STATE STREET CORP | $1 144 176 449 | 6 507 288 | 6,24% | Actions |
| WCM INVESTMENT MANAGEMENT, LLC | $1 124 033 551 | 6 206 701 | 6,13% | Actions |
| PRIMECAP MANAGEMENT CO/CA/ | $617 980 735 | 3 514 649 | 3,37% | Actions |
| FMR LLC | $523 532 529 | 2 977 492 | 2,85% | Actions |
| Corvex Management LP | $497 695 958 | 2 830 552 | 2,71% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $412 561 415 | 2 354 283 | 2,25% | Actions |
| LOOMIS SAYLES & CO L P | $298 854 639 | 1 699 679 | 1,63% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $284 828 951 | 1 619 911 | 1,55% | Actions |
| JANUS HENDERSON GROUP PLC | $246 405 738 | 1 999 073 | 1,34% | Actions |
| Sessa Capital IM, L.P. | $196 643 700 | 1 118 374 | 1,07% | Actions |
| AMERIPRISE FINANCIAL INC | $191 377 137 | 1 088 353 | 1,04% | Actions |
| ARK Investment Management LLC | $183 744 158 | 1 045 010 | 1,00% | Actions |
| Senvest Management, LLC | $177 362 886 | 1 008 718 | 0,97% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $167 266 376 | 951 296 | 0,91% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $167 050 984 | 950 071 | 0,91% | Actions |
| FIRST TRUST ADVISORS LP | $159 563 763 | 907 489 | 0,87% | Actions |
| PointState Capital LP | $151 602 384 | 862 210 | 0,83% | Actions |
| LETKO, BROSSEAU & ASSOCIATES INC | $145 990 418 | 830 293 | 0,80% | Actions |
| NORGES BANK | $145 424 246 | 827 073 | 0,79% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $145 348 463 | 826 642 | 0,79% | Actions |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $129 791 552 | 738 165 | 0,71% | Actions |
| GUARDCAP ASSET MANAGEMENT Ltd | $128 748 557 | 740 132 | 0,70% | Actions |
| Chevy Chase Trust Holdings, LLC | $127 952 370 | 727 705 | 0,70% | Actions |
| Quantinno Capital Management LP | $117 941 015 | 670 767 | 0,64% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $111 675 435 | 635 133 | 0,61% | Actions |
| Amova Asset Management Americas, Inc. | $108 658 017 | 617 972 | 0,59% | Actions |
| ALLIANCEBERNSTEIN L.P. | $108 597 114 | 881 041 | 0,59% | Actions |
| Alyeska Investment Group, L.P. | $102 285 586 | 581 730 | 0,56% | Actions |
| RHUMBLINE ADVISERS | $98 590 641 | 560 716 | 0,54% | Actions |
| BROWN ADVISORY INC | $96 835 682 | 550 735 | 0,53% | Actions |
| Stephens Investment Management Group LLC | $94 583 529 | 537 926 | 0,52% | Actions |
| Casdin Capital, LLC | $93 189 900 | 530 000 | 0,51% | Actions |
| NORDEA INVESTMENT MANAGEMENT AB | $90 531 934 | 515 499 | 0,49% | Actions |
| Caisse de depot et placement du Quebec | $86 532 800 | 492 139 | 0,47% | Actions |
| GOLDMAN SACHS GROUP INC | $84 217 839 | 478 973 | 0,46% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $82 394 290 | 468 602 | 0,45% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $82 176 517 | 467 365 | 0,45% | Actions |
| Spyglass Capital Management LLC | $80 665 002 | 458 767 | 0,44% | Actions |
| BlackRock, Inc. | $77 542 612 | 441 009 | 0,42% | Actions |
| Swiss National Bank | $73 918 932 | 420 400 | 0,40% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $72 810 204 | 414 094 | 0,40% | Actions |
| M&G PLC | $71 140 608 | 404 208 | 0,39% | Actions |
| Southpoint Capital Advisors LP | $70 332 000 | 400 000 | 0,38% | Actions |
| National Pension Service | $65 031 780 | 369 856 | 0,35% | Actions |
| KEYBANK NATIONAL ASSOCIATION/OH | $64 398 474 | 366 254 | 0,35% | Actions |
| LMR Partners LLP | $62 631 877 | 356 207 | 0,34% | Actions |
| Gotham Asset Management, LLC | $62 627 657 | 356 183 | 0,34% | Actions |
| Patient Capital Management, LLC | $60 716 695 | 345 314 | 0,33% | Actions |
| BANK OF AMERICA CORP /DE/ | $59 969 108 | 341 063 | 0,33% | Actions |
| California Public Employees Retirement System | $59 582 457 | 338 864 | 0,32% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $58 761 155 | 334 193 | 0,32% | Actions |
| BAILLIE GIFFORD & CO | $57 855 807 | 329 044 | 0,32% | Actions |
| Douglas Lane & Associates, LLC | $57 088 338 | 324 679 | 0,31% | Actions |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $55 453 265 | 315 380 | 0,30% | Actions |
| Robeco Institutional Asset Management B.V. | $54 117 836 | 307 785 | 0,30% | Actions |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $53 037 713 | 301 642 | 0,29% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $51 879 696 | 295 056 | 0,28% | Actions |
| Ilex Capital Partners (UK) LLP | $50 837 904 | 289 131 | 0,28% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $49 655 000 | 282 402 | 0,27% | Actions |
| Pictet Asset Management Holding SA | $48 335 824 | 268 581 | 0,26% | Actions |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $48 163 179 | 273 919 | 0,26% | Actions |
| RAYMOND JAMES FINANCIAL INC | $47 981 443 | 272 885 | 0,26% | Actions |
| IEQ CAPITAL, LLC | $47 110 622 | 267 932 | 0,26% | Actions |
| JENNISON ASSOCIATES LLC | $46 171 981 | 262 594 | 0,25% | Actions |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $45 645 123 | 348 011 | 0,25% | Actions |
| ROYAL BANK OF CANADA | $43 456 000 | 247 148 | 0,24% | Actions |
| ASR Vermogensbeheer N.V. | $43 316 775 | 246 356 | 0,24% | Actions |
| AustralianSuper Pty Ltd | $41 627 928 | 236 751 | 0,23% | Actions |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $41 306 863 | 234 925 | 0,23% | Actions |
| BAMCO INC /NY/ | $39 929 938 | 227 094 | 0,22% | Actions |
| Legal & General Group Plc | $39 368 159 | 223 899 | 0,21% | Actions |
| Cannell & Spears LLC | $36 928 050 | 210 021 | 0,20% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $33 545 023 | 190 781 | 0,18% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $33 236 344 | 189 272 | 0,18% | Actions |
| Eagle Health Investments LP | $32 952 828 | 187 413 | 0,18% | Actions |
| VANGUARD GROUP INC | $32 906 339 | 250 887 | 0,18% | Actions |
| MORGAN STANLEY | $32 416 825 | 184 364 | 0,18% | Actions |
| Baird Financial Group, Inc. | $31 122 437 | 177 003 | 0,17% | Actions |
| BARCLAYS PLC | $31 054 392 | 176 616 | 0,17% | Actions |
| Howard Capital Management, LLC | $31 000 587 | 176 310 | 0,17% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30 910 914 | 175 800 | 0,17% | Option d'achat |
| Mitsubishi UFJ Asset Management Co., Ltd. | $30 501 230 | 173 470 | 0,17% | Actions |
| PFA Pension, Forsikringsaktieselskab | $30 069 940 | 171 017 | 0,16% | Actions |
| OSTRUM ASSET MANAGEMENT | $29 637 026 | 168 555 | 0,16% | Actions |
| Artisan Partners Limited Partnership | $29 485 109 | 167 691 | 0,16% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $29 159 125 | 236 566 | 0,16% | Actions |
| Mitsubishi UFJ Trust & Banking Corp | $29 130 459 | 165 674 | 0,16% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $28 451 052 | 161 810 | 0,16% | Actions |
| CIBC Private Wealth Group LLC | $28 430 314 | 299 361 | 0,15% | Actions |
| Hardman Johnston Global Advisors LLC | $28 131 745 | 159 994 | 0,15% | Actions |
| Retirement Systems of Alabama | $27 515 109 | 156 487 | 0,15% | Actions |
| PEAK6 LLC | $25 653 597 | 145 900 | 0,14% | Option d'achat |
| Assenagon Asset Management S.A. | $24 616 727 | 140 003 | 0,13% | Actions |
| Candriam S.C.A. | $24 288 272 | 138 268 | 0,13% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $24 059 346 | 136 833 | 0,13% | Actions |
| NORTH STAR ASSET MANAGEMENT INC | $23 514 310 | 190 770 | 0,13% | Actions |
| Capital Investment Services of America, Inc. | $22 808 316 | 129 718 | 0,12% | Actions |
Initiés de la société 88 initiés · 50 dirigeants · 29 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jacob Thaysen | Chief Executive Officer | 5 mars 2026 A | 109 073 | 0 | 0 | $0 |
| Francis A Desouza | President and CEO | 1 mars 2023 A | 120 992 | 0 | 0 | $0 |
| Ankur Dhingra | SVP, Chief Financial Officer | 5 mars 2026 A | 34 264 | 0 | 0 | $0 |
| Joydeep Goswami | SVP, Chief Financial Officer | 5 mars 2024 A | 24 478 | 0 | 0 | $0 |
| Sam Samad | SVP and CFO | 1 mars 2022 A | 11 297 | 0 | 0 | $0 |
| Timothy M Kish | VP Finance & CFO | 2 mars 2005 A | — | 0 | 0 | $0 |
| John R Stuelpnagel | Sr VP and COO | 27 mars 2008 M | 337 836 | 0 | 0 | $0 |
| Scott M Davies | Chief Legal Officer | 30 juillet 2026 S | 20 338 | 0 | 5 | $-531 273 |
| Patricia Leckman | SVP, Chief People Officer | 5 juin 2026 S | 21 259 | 0 | 9 | $-529 720 |
| Scott D Ericksen | VP, Chief Accounting Officer | 29 mai 2026 S | 14 446 | 0 | 2 | $-305 150 |
| Christensen Jakob Wedel | SVP, Strategy/Corp Development | 6 mai 2026 S | 15 056 | 0 | 2 | $-168 297 |
| Steven Barnard | SVP, Chief Technology Officer | 5 mars 2026 A | 41 335 | 0 | 0 | $0 |
| Kevin Carl Pegels | Chief of Global Operations | 5 mars 2026 A | 29 038 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Chief Commercial Officer | 5 juillet 2025 F | 41 942 | 0 | 0 | $0 |
| Carissa Rollins | SVP, Chief Information Officer | 5 avril 2025 F | 18 447 | 0 | 0 | $0 |
| Charles Dadswell | SVP, General Counsel | 13 septembre 2024 D | 20 586 | 0 | 0 | $0 |
| Kathryne Gambrell Reeves | SVP, Chief Marketing Officer | 5 mars 2024 A | 17 965 | 0 | 0 | $0 |
| Aimee L Hoyt | SVP, Chief People Officer | 7 novembre 2023 S | 8 314 | 0 | 0 | $0 |
| Susan H Tousi | SVP, Chief Commercial Officer | 5 novembre 2023 F | 43 743 | 0 | 0 | $0 |
| Alexander Aravanis | SVP, Chief Technology Officer | 5 juillet 2023 F | 12 587 | 0 | 0 | $0 |
| John Edward Frank | Chief Public Affairs Officer | 5 mai 2023 F | 9 166 | 0 | 0 | $0 |
| Phillip G. Febbo | SVP Chief Medical Officer | 1 mars 2023 A | 14 786 | 0 | 0 | $0 |
| Jose Torres | VP, Chief Accounting Officer | 5 mai 2022 F | 1 748 | 0 | 0 | $0 |
| Karen K Mcginnis | VP, Chief Accounting Officer | 18 février 2021 S | 1 538 | 0 | 0 | $0 |
| Robert P Ragusa | SVP, Global Quality & Ops | 17 février 2021 M | 9 617 | 0 | 0 | $0 |
| Mostafa Ronaghi | SVP, Entrepreneurial Devlopmt | 10 décembre 2020 S | 80 162 | 0 | 0 | $0 |
| Mark Van Oene | SVP Chief Commercial Officer | 5 novembre 2020 F | 16 575 | 0 | 0 | $0 |
| Omead Ostadan | SVP Mktg, Prod & Strat Plan | 11 mai 2020 S | 17 172 | 0 | 0 | $0 |
| Malcolm Garret Hampton | SVP Clinical Genomics Group | 9 janvier 2020 F | 6 598 | 0 | 0 | $0 |
| Marc Stapley | EVP Strategy & Corp Developmt | 6 décembre 2018 S | 6 957 | 0 | 0 | $0 |
| Michel Bouchard | Chief Accounting Officer | 6 novembre 2017 F | 9 538 | 0 | 0 | $0 |
| Christian O Henry | EVP & Chief Commercial Officer | 30 janvier 2017 F | 17 531 | 0 | 0 | $0 |
| Tristan Orpin | EVP Clinical Genomics | 7 novembre 2016 F | 118 259 | 0 | 0 | $0 |
| Nicholas Naclerio | Sr VP, Corporate Development | 21 mars 2016 S | 30 020 | 0 | 0 | $0 |
| Richard Klausner | Sr VP, Chief Medical Officer | 29 janvier 2016 F | 22 847 | 0 | 0 | $0 |
| Gregory Heath | Sr VP & General Manager | 17 décembre 2013 M | 26 740 | 0 | 0 | $0 |
| Mark L Lewis | Sr VP & General Manager | 1 novembre 2013 M | 44 837 | 0 | 0 | $0 |
| Matthew L. Posard | Sr VP & General Manager | 30 mai 2013 M | 30 858 | 0 | 0 | $0 |
| Christian Cabou | Sr VP & General Counsel | 23 avril 2013 M | 45 553 | 0 | 0 | $0 |
| Joel Mccomb | Sr VP & General Manager | 28 janvier 2010 F | 6 595 | 0 | 0 | $0 |
| John West | Sr. VP & GM DNA Sequencing | 8 novembre 2007 M | 82 062 | 0 | 0 | $0 |
| Arthur Holden | Sr VP Corp & Market Dev | 25 janvier 2007 A | — | 0 | 0 | $0 |
| David L Barker | Chief Scientific Officer | 29 novembre 2005 S | 137 636 | 0 | 0 | $0 |
| Alan Kersey | V.P. & Site Manager | 31 août 2005 S | 48 582 | 0 | 0 | $0 |
| Robert C Kain | Vice President Engineering | 23 août 2005 S | 125 311 | 0 | 0 | $0 |
| Kirk Malloy | V.P. of Customer Solutions | 9 mai 2005 A | — | 0 | 0 | $0 |
| David C Douglas | Vice President Manufacturing | 2 mai 2005 S | 0 | 0 | 0 | $0 |
| Scott D Kahn | Chief Information Officer | 6 avril 2005 A | — | 0 | 0 | $0 |
| Arnold R Oliphant | VP Scientific Operations | 28 février 2005 M | 0 | 0 | 0 | $0 |
| Noemi C Espinosa | VP Intellectual Property | 25 février 2005 A | 204 704 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Illumina, Inc. ×2 dépôts | 5 février 2007 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 160 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| GNOM · Global X Funds | 4,82% | 16 512 NS | 31 mai 2026 | N-PORT |
| ARKG · ARK ETF Trust | 4,03% | 392 835 NS | 30 avril 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 3,74% | 1 118 887 SH | 8 août 2026 | Quotidien |
| PBE · Invesco Exchange-Traded Fund Trust | 3,10% | 59 706 SH | 8 août 2026 | Quotidien |
| AGIQ · Tidal Trust I | 2,49% | 1 730 NS | 31 mai 2026 | N-PORT |
| IBB · iShares Trust | 2,25% | 1 108 116 SH | 8 août 2026 | Quotidien |
| ABOT · Abacus FCF ETF Trust | 2,09% | 727 NS | 30 avril 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,95% | 8 210 NS | 30 avril 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,94% | 8 235 SH | 8 août 2026 | Quotidien |
| PTH · Invesco Exchange-Traded Fund Trust | 1,83% | 24 099 SH | 8 août 2026 | Quotidien |
| MTRA · Invesco Actively Managed Exchange-T… | 1,46% | 11 131 SH | 8 août 2026 | Quotidien |
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 1,45% | 37 005 NS | 30 avril 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,37% | 86 304 SH | 8 août 2026 | Quotidien |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,35% | 188 077 NS | 30 avril 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,34% | 92 110 NS | 30 avril 2026 | N-PORT |
| BIB · ProShares Trust | 1,25% | 5 653 NS | 31 mai 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,21% | 3 691 NS | 30 avril 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 1,20% | 2 373 NS | 31 mai 2026 | N-PORT |
| ARKK · ARK ETF Trust | 1,20% | 614 284 NS | 30 avril 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 1,14% | 6 746 NS | 31 mai 2026 | N-PORT |
| ANEW · ProShares Trust | 1,06% | 502 NS | 31 mai 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1,01% | 1 224 NS | 30 avril 2026 | N-PORT |
| MIDE · DBX ETF Trust | 1,01% | 207 NS | 29 mai 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,99% | 169 737 NS | 31 mai 2026 | N-PORT |
| XJH · iShares Trust | 0,92% | 20 448 SH | 8 août 2026 | Quotidien |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,87% | 20 389 SH | 8 août 2026 | Quotidien |
| IJK · iShares Trust | 0,85% | 478 050 SH | 8 août 2026 | Quotidien |
| IJH · iShares Trust | 0,81% | 5 220 464 SH | 8 août 2026 | Quotidien |
| JOET · Virtus ETF Trust II | 0,78% | 14 553 NS | 30 avril 2026 | N-PORT |
| IJJ · iShares Trust | 0,77% | 354 472 SH | 8 août 2026 | Quotidien |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,75% | 80 617 SH | 8 août 2026 | Quotidien |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,73% | 244 355 SH | 8 août 2026 | Quotidien |
| FLCC · Federated Hermes ETF Trust | 0,70% | 5 235 NS | 31 mai 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,70% | 59 759 SH | 8 août 2026 | Quotidien |
| ITAN · EA Series Trust | 0,60% | 3 264 NS | 29 mai 2026 | N-PORT |
| PJFM · PGIM ETF Trust | 0,59% | 600 NS | 29 mai 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,57% | 17 611 NS | 30 avril 2026 | N-PORT |
| MVV · ProShares Trust | 0,54% | 5 283 NS | 31 mai 2026 | N-PORT |
| IYH · iShares Trust | 0,48% | 91 002 SH | 8 août 2026 | Quotidien |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 47 842 NS | 30 avril 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,47% | 12 715 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,39% | 448 145 SH | 8 août 2026 | Quotidien |
| MIDU · Direxion Shares ETF Trust | 0,38% | 2 532 NS | 30 avril 2026 | N-PORT |
| FLCG · Federated Hermes ETF Trust | 0,38% | 13 255 NS | 31 mai 2026 | N-PORT |
| UMDD · ProShares Trust | 0,38% | 738 NS | 31 mai 2026 | N-PORT |
| SMIZ · Zacks Trust | 0,35% | 5 614 NS | 31 mai 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,35% | 951 944 SH | 8 août 2026 | Quotidien |
| BFOR · ALPS ETF Trust | 0,31% | 4 141 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,31% | 70 313 NS | 30 avril 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0,31% | 444 011 NS | 30 avril 2026 | N-PORT |